{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"230","upperLimit":"418","value":"310"},{"groupId":"OG001","lowerLimit":"25","upperLimit":"55","value":"37"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Age<24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"180","upperLimit":"437","value":"281"},{"groupId":"OG001","lowerLimit":"26","upperLimit":"69","value":"42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"28"}],"units":"Participants"}],"title":"Age>=24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"258","upperLimit":"431","value":"333"},{"groupId":"OG001","lowerLimit":"30","upperLimit":"57","value":"42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"78"},{"groupId":"OG001","value":"64"}],"units":"Participants"}],"title":"Baseline HIV viral load <=75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"57","upperLimit":"267","value":"123"},{"groupId":"OG001","lowerLimit":"7","upperLimit":"86","value":"25"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Baseline HIV viral load >75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"209","upperLimit":"511","value":"327"},{"groupId":"OG001","lowerLimit":"26","upperLimit":"77","value":"45"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"}],"units":"Participants"}],"title":"Baseline CD4 <=500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"208","upperLimit":"381","value":"282"},{"groupId":"OG001","lowerLimit":"25","upperLimit":"52","value":"36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Baseline CD4 >500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"240","upperLimit":"476","value":"338"},{"groupId":"OG001","lowerLimit":"29","upperLimit":"62","value":"42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"44"}],"units":"Participants"}],"title":"Nadir CD4 <=350"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"185","upperLimit":"387","value":"268"},{"groupId":"OG001","lowerLimit":"21","upperLimit":"62","value":"36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"}],"units":"Participants"}],"title":"Nadir CD4>350"}],"denoms":[{"counts":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"73"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 18 at 7 and 24 months","dispersionType":"95% Confidence Interval","groups":[{"description":"Month 7 visit after enrollment","id":"OG000","title":"Month 7 Visit"},{"description":"Month 24 visit after enrollment","id":"OG001","title":"Month 24 Visit"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination and who were sero-negative for HPV 18 at baseline with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"at 7 and 24 Months","title":"Geometric Mean Titers for HPV 18 According to Participant Age, HIV Viral Load, CD4+ T Cell Count, and Nadir CD4 Level","type":"SECONDARY","unitOfMeasure":"mMU/mL"}